Methylene-tetrahydrofolate reductase gene C677T and A1298C polymorphisms as a risk factor for Crimean-Congo hemorrhagic fever

References

• Ergönül, O. Crimean-Congo Haemorrhagic Fever. Lancet Infect. Dis. 2006, 6, 203–214.
   PubMed Web of Science ®Google Scholar
• Gözalan, A.; Esen, B.; Fitzner, J.; Tapar, F. S.; Ozkan, A. P.; Georges-Courbot, M. C.; Uzun, R.; Gumuslu, F.; Akin, L.; Zeller, H. Crimean-Congo Haemorrhagic Fever Cases in Turkey. Scand. J. Infect. Dis. 2007, 39, 332–336. DOI: 10.1080/00365540601053014.
   PubMed Web of Science ®Google Scholar
• Hoogstraal, H. The Epidemiology of Tick-Borne Crimean-Congo Hemorrhagic Fever in Asia, Europe, and Africa. J. Med. Entomol. 1979, 15, 307–417.
   PubMed Web of Science ®Google Scholar
• Wei, Q.; Shen, H.; Wang, L. E.; Duphorne, C. M.; Pillow, P. C.; Guo, Z.; Qiao, Y.; Spitz, M. R. Association between Low Dietary Folate Intake and Suboptimal Cellular DNA Repair Capacity. Cancer Epidemiol. Biomarkers Prev. 2003, 12, 963–969.
   PubMed Web of Science ®Google Scholar
• Bailey, L. B.; Gregory, J. F.III. Polymorphisms of Methylenetetrahydrofolate Reductase and Other Enzymes: Metabolic Significance, Risks and Impact on Folate Requirement. J. Nutr. 1999, 129, 919–922.
   PubMed Web of Science ®Google Scholar
• Duthie, S. J. Folate and Cancer: How DNA Damage, Repair and Methylation Impact on Colon Carcinogenesis. J. Inherit. Metab. Dis. 2011, 34, 101–109.
   PubMed Web of Science ®Google Scholar
• Goyette, P.; Sumner, J. S.; Milos, R.; Duncan, A. M. V.; Rosenblatt, D. S.; Matthews, R. G.; Rozen, R. Human Methylenetetrahydrofolate Reductase: Isolation of cDNA, Mapping and Mutation Identification. Nat. Genet. 1994, 7, 195–200. DOI: 10.1038/ng0694-195.
   PubMed Web of Science ®Google Scholar
• Goyette, P.; Pai, A.; Milos, R.; Frosst, P.; Tran, P.; Chen, Z.; Chan, M.; Rozen, R. Gene Structure of Human and Mouse Methylenetetrahydrofolate Reductase (MTHFR). Mamm. Genome 1998, 9, 652–656. DOI: 10.1007/s003359900838.
   PubMed Web of Science ®Google Scholar
• Frosst, P.; Blom, H. J.; Milos, R.; Goyette, P.; Sheppard, C. A.; Matthews, R. G.; Boers, G. J. H.; den Heijer, M.; Kluijtmans, L. A. J.; van den Heuvel, L. P. A Candidate Genetic Risk Factor for Vascular Disease: A Common Mutation in Methylenetetrahydrofolate Reductase. Nat. Genet. 1995, 10, 111–113.
   PubMed Web of Science ®Google Scholar
• van der Put, N. M. J.; Gabreels, F.; Stevens, E. M. B.; Smeitink, J. A. M.; Trijbels, F. J. M.; Eskes, T. K. A. B.; van den Heuvel, L. P.; Blom, H. J. A Second Mutation in the Methylenetetrahydrofolate Reductase Gene: An Additional Risk Factor for Neural-Tube Defects? Am. J. Hum. Genet. 1998, 62, 1044–1051. DOI: 10.1086/301825.
   PubMed Web of Science ®Google Scholar
• Ergonul, O.; Celikbas, A.; Baykam, N.; Eren, S.; Dokuzoguz, B. Analysis of Risk Factors among Patients with Crimean-Congo Haemorrhagic Fever Virus Infection: Severity Criteria Revisited. Clin. Microbiol. Infect. 2006, 12, 551–554. DOI: 10.1111/j.1469-0691.2006.01445.x.
   PubMed Web of Science ®Google Scholar
• Engin, A.; Arslan, S.; Kizildag, S.; Oztürk, H.; Elaldi, N.; Dökmetas, I.; Bakir, M. Toll-like Receptor 8 and 9 Polymorphisms in Crimean-Congo Hemorrhagic Fever. Microbes Infect. 2010, 12, 1071–1078.
   PubMed Web of Science ®Google Scholar
• Arslan, S.; Engin, A. Relationship between NF-κB1 and NF-κBIA Genetic Polymorphisms and Crimean-Congo Hemorrhagic Fever. Scand. J. Infect. Dis. 2012, 44, 138–143. DOI: 10.3109/00365548.2011.623313.
   PubMed Web of Science ®Google Scholar
• Arslan, S.; Engin, A.; Özbilüm, N.; Bakır, M. Toll-like Receptor 7 Gln11Leu, c.4-151A/G, and +1817G/T Polymorphisms in Crimean Congo Hemorrhagic Fever. J. Med. Virol. 2015, 87, 1090–1095.
   PubMed Web of Science ®Google Scholar
• Yilmaz, M.; Elaldi, N.; Bagci, B.; Sari, I.; Gümüs, E.; Yelkovan, I. Effect of Tumour Necrosis Factor-Alpha and Interleukin-6 Promoter Polymorphisms on Course of Crimean-Congo Hemorrhagic Fever in Turkish Patients. J. Vector Borne Dis. 2015, 52, 30–35.
   PubMed Web of Science ®Google Scholar
• Elaldi, N.; Yilmaz, M.; Bagci, B.; Yelkovan, I.; Bagci, G.; Gozel, M. G.; Engin, A.; Bakir, M.; Dokmetas, I. Dokmetas, I. Crimean-Congo Hemorrhagic Fever Prognosis in a Turkish Population Range. J. Med. Virol. 2016, 88, 1159–1167. DOI: 10.1002/jmv.24456.
   PubMed Web of Science ®Google Scholar
• Engin, A.; Arslan, S.; Özbilüm, N.; Bakir, M. Is There Any Relationship between Tolllike Receptor 3 c.1377C/T and -7C/a Polymorphisms and Susceptibility to Crimean Congo Hemorrhagic Fever? J. Med. Virol. 2016, 88, 1690–1696. DOI: 10.1002/jmv.24519.
   PubMed Web of Science ®Google Scholar
• Rustemoglu, A.; Ekinci, D.; Nursal, A. F.; Barut, S.; Duygu, F.; Günal, Ö. The Possible Role of CCR5Δ32 Mutation in Crimean-Congo Hemorrhagic Fever Infection. J. Med. Virol. 2017, 89, 1714–1719.
   PubMed Web of Science ®Google Scholar
• Kızıldağ, S.; Arslan, S.; Özbilüm, N.; Engin, A.; Bakır, M. Effect of TLR10 (2322A/G, 720A/C, and 992T/A) Polymorphisms on the Pathogenesis of Crimean Congo Hemorrhagic Fever Disease. J. Med. Virol. 2018, 90, 19–25.
   PubMed Web of Science ®Google Scholar
• Say Coskun, U. S.; Nursal, A. F.; Gunes, F.; Rustemoglu, A.; Yayli, A.; Karakus, N.; Barut, H. S.; Yigit, S. Significance of IL-1Ra and IL-6 Gene Variants in Turkish Patients with Crimean-Congo Hemorrhagic Fever. Asian Pac. J. Trop. Biomed. 2019, 9, 85–90. DOI: 10.4103/2221-1691.250864.
   Web of Science ®Google Scholar
• Karakus, N.; Yigit, S.; Duygu, F.; Barut, S.; Rustemoglu, A.; Basol, N. Effects of Paraoxonase-1 Variants on Course of Severity and Mortality of Crimean-Congo Hemorrhagic Fever. Gene 2019, 687, 188–192.
   PubMed Web of Science ®Google Scholar
• Bronowicki, J.-P.; Abdelmouttaleb, I.; Peyrin-Biroulet, L.; Venard, V.; Khiri, H.; Chabi, N.; Amouzou, E. K.; Barraud, H.; Halfon, P.; Sanni, A.; et al. Methylenetetrahydrofolate Reductase 677 T Allele Protects against Persistent HBV Infection in West Africa. J. Hepatol. 2008, 48, 532–539. DOI: 10.1016/j.jhep.2007.11.017.
   PubMed Web of Science ®Google Scholar
• Ponti, G.; Pastorino, L.; Manfredini, M.; Ozben, T.; Oliva, G.; Kaleci, S.; Iannella, R.; Tomasi, A. COVID-19 Spreading across World Correlates with C677T Allele of the Methylenetetrahydrofolate Reductase (MTHFR) Gene Prevalence. J. Clin. Lab. Anal. 2021, 35, e23798.
   PubMed Web of Science ®Google Scholar
• Carvalho, S. C. R.; Vasconcelos, L. R. S.; Fonseca, L. D.; Carmo, R. F.; Tomitão, M. T.; Aroucha, D. C. B. L.; Pereira, L. M. M. B.; Stefano, J. T.; Ribeiro-Júnior, U.; Oliveira, C. P.; et al. Methylene Tetrahydrofolate Reductase (MTHFR) and Vascular Endothelial Growth Factor (VEGF) Polymorphisms in Brazilian Patients with Hepatitis C Virus (HCV)-Related Hepatocellular Carcinoma (HCC). Clinics (Sao Paulo) 2021, 76, e2881.
   PubMed Web of Science ®Google Scholar
• Hiraoka, M.; Kagawa, Y. Genetic Polymorphisms and Folate Status. Congenit Anom (Kyoto) 2017, 57, 142–149. DOI: 10.1111/cga.12232.
   PubMed Web of Science ®Google Scholar